|View printer-friendly version|
|April 26, 2000 3:23 p.m.|
|Teva Pharmaceutical Receives First FDA Approval of Ketoconazole 2% Cream|
Jerusalem, Israel, April 26, 2000 - Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) today announced that it had received from the US Food and Drug Administration an approval to manufacture and market Ketoconazole 2% Cream. Teva USA will launch the product immediately.